StonvexLoading…
StonvexStonvexStonvexCore line items from RMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $5.15B | $4.69B | $4.22B | $3.58B |
Operating Income | $1.69B | $1.32B | $1.13B | $1.00B |
Net Income | $1.40B | $1.02B | $897.56M | $779.44M |
EPS (Diluted) | $9.51 | $6.92 | $6.09 | $5.30 |
Total Assets | $8.17B | $6.87B | $6.75B | $5.10B |
Total Liabilities | $2.21B | $2.01B | $2.62B | $1.74B |
Cash & Equivalents | $1.21B | $238.36M | $227.89M | $273.71M |
Free Cash Flow OCF − CapEx | $1.66B | $1.30B | $573.63M | $216.31M |
Shares Outstanding | 146.39M | 146.90M | 147.06M | 146.41M |